Kemira has completed its share buyback program announced in July 2025

Kemira completed the share buyback program announced July 18, 2025, repurchasing the maximum 5,000,000 shares (≈3.2% of outstanding) between July 22 and Dec. 16 at an average price of €19.23, reducing equity by roughly €96m; the program was authorized up to €100m. Repurchases were executed in public trading on Nasdaq Helsinki using non-restricted equity and will be cancelled, leaving Kemira with 896,004 own shares after cancellation, a capital-return move that will lower share count and concentrate ownership. The action comes from a company that reported €2.9bn in 2024 revenue and reinforces its shareholder-return policy while modestly adjusting capital structure.

Analysis

Kemira announced completion of the share buyback program authorized at the 2025 AGM, repurchasing the maximum 5,000,000 shares (approximately 3.2% of outstanding) between July 22 and December 16, 2025 at an average price of €19.23. The program used up to €100m in authorization and reduced equity by roughly €96m; repurchases were executed in public trading on Nasdaq Helsinki using the company’s non-restricted shareholders’ equity.

The repurchased shares will be cancelled, after which Kemira will hold 896,004 own shares, which further reduces the total share count and concentrates ownership. Given the modest 3.2% reduction, the buyback should provide limited but tangible EPS and ROE support and a signal of management’s preference for capital returns versus alternative uses.

Market signals classify the news as mildly positive with a low market-impact score, reflecting that the action is pro-shareholder but not transformative for a company that reported €2.9bn revenue in 2024 and employs ~4,700 people. Investors should note the immediate capital-structure effect (≈€96m equity reduction) and monitor upcoming financial disclosures for changes to leverage, dividend policy or further capital-allocation moves.

Key Decisions for Investors

• Consider holding or modestly increasing exposure as the 3.2% buyback and planned cancellation should provide limited EPS/share support and a positive governance signal
• Monitor balance-sheet metrics and liquidity in the next quarterly report given the ~€96m reduction in equity and use of non-restricted equity to fund the program
• Do not assume a material re-rating solely from this buyback—wait for confirmation from cancelled-share accounting, near-term results and management commentary before adding size to positions
• Watch for follow-on capital-return actions or shifts in dividend policy as the clearest indicators of sustained shareholder-return focus